Pfizer Vaccines launches global centers of excellence network

Vaccines |  News | 0 Comment | 24 Jan, 2020

Pfizer Inc. has announced the launch of its Vaccines Division’s Centers of Excellence Network, a global program of collaborations with academic institutions to conduct real-world epid...Read more

Sinovac receives China's approval for varicella vaccine

Vaccines |  News | 0 Comment | 31 Dec, 2019

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has announced that the China National Medical Products Administration (NMPA) has approved and issued a Product li...Read more

Merck gets FDA nod for Ebola vaccine

Vaccines |  News | 0 Comment | 23 Dec, 2019

The U.S. Food and Drug Administration has announced the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in ind...Read more

Vaccitech provides update for its Phase 2 Universal Influenza studies

Vaccines |  News | 0 Comment | 25 Nov, 2019

Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases, reports successful recruitment and vaccination for its ...Read more

NEC, VAXIMM to advance personalized neoantigen cancer vaccines

Vaccines |  News | 0 Comment | 15 Nov, 2019

Japan based NEC Corporation, a leader in IT and network technologies, and VAXIMM AG, a Swiss/German biotech company focused on developing oral T-cell immunotherapies, announced that the com...Read more

Takeda’s Dengue vaccine candidate reveals protection in children

Vaccines |  News | 0 Comment | 08 Nov, 2019

Japan based Takeda Pharmaceutical Company Limited has announced that results from the primary endpoint analysis of the ongoing pivotal Phase 3 Tetravalent Immunization against Den...Read more

FDA approves Sanofi’s Influenza Vaccine for older people

Vaccines |  News | 0 Comment | 05 Nov, 2019

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 y...Read more

The Union reports efficacy of its TB Vaccine Candidate

Vaccines |  News | 0 Comment | 30 Oct, 2019

International Union Against Tuberculosis and Lung Disease (The Union) headquartered in France, announces the Phase IIb Trial results of its Tuberculosis Vaccine Candidate GSK/IAVI M72. ...Read more

NIH awards contracts to advance tuberculosis immunology research

Vaccines |  News | 0 Comment | 27 Sep, 2019

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immu...Read more

Alwaleed Philanthropies invests $5 M in global fight for vaccines

Vaccines |  News | 0 Comment | 02 Sep, 2019

Alwaleed Philanthropies, chaired by HRH Prince Alwaleed Bin Talal Bin Abdulaziz AlSaud, the global philanthropic foundation, has made a fresh commitment to preventing the spread of dis...Read more

Crozet partners with PHV to develop Nipah virus vaccine

Vaccines |  News | 0 Comment | 28 Aug, 2019

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (PHV), to advance the development and manufacture of a vaccine against ...Read more

Zuellig Pharma, NICVB, NIHE team up for accessibility of vaccines

Vaccines |  News | 0 Comment | 23 Apr, 2019

The National Institute of Vaccines and Medical Biologicals (NICVB), the National Institute of Hygiene and Epidemiology (NIHE) and Zuellig Pharma have officially announced a project to expan...Read more

The Govt. of EG, US Energy Companies & Sanaria collaborate for malaria vaccine

Vaccines |  News | 0 Comment | 11 Apr, 2019

Sanaria Inc. and the Government of Equatorial Guinea last week signed an agreement that continues their joint commitment to develop Sanaria® PfSPZ Vaccine as a tool for malari...Read more

Serum Institute launches biggest immunisation awareness drive in India

Vaccines |  News | 0 Comment | 22 Feb, 2019

Serum Institute of India (SII), vaccine manufacturer launched a nation-wide vaccination and immunisation campaign called ‘Swasth Immunised India’ in association with Network18, ...Read more

Vertex announces EC approval for ORKAMBI

Vaccines |  News | 0 Comment | 24 Jan, 2019

Global Biotechnology company, Vertex Pharmaceuticals has announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatm...Read more

Exelixis announces USFDA approval of CABOMETYX

Vaccines |  News | 0 Comment | 16 Jan, 2019

Oncology focused biotechnology company, Exelixis has announced that USFDA has approved CABOMETYX tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated wi...Read more

AstraZeneca’s Bevespi Aerosphere approved in the EU

Vaccines |  News | 0 Comment | 03 Jan, 2019

AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formoterol fumarate) in a pressurised metered-dose inhaler (pMDI) as a maint...Read more

FDA approves Sanofi & MSD’s VAXELIS™

Vaccines |  News | 0 Comment | 03 Jan, 2019

The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate [Meningoc...Read more